Explore the role of transcription factor biology in drug discovery and how it impacts our understanding of disease mechanisms ...

January 15, 2026) - Trinity One Metals Ltd. (TSXV: TOM) (OTC Pink: ARJNF) (FSE: 5D5) (the "Company" or "Trinity One") is ...

Cereals have natural resistance to pathogenic fungi, but powdery mildew, for example, can overcome this resistance. A team at ...

Cereals have natural resistance genes that can protect them from disease-causing fungi. However, certain fungi, such as powdery mildew, are known to be able to overcome such resistance. A team at the ...

Amyloid-targeted monoclonal antibodies are the first disease-modifying therapies (DMTs) approved for Alzhemier’s disease (AD). Aducanumab received accelerated approval by the FDA but was not fully ...

Introduction Globally, up to 15% of children and adolescents experience a mental health (MH) condition. In the UK, an increasing number of children and young people (CYP) are presenting to acute ...

The Phase 1b trial consisted of 24 patients with Parkinson’s disease, who received twice-weekly dosing of either HER-096 or placebo over a four-week period. The trial’s exploratory biomarker program ...

Research shows that Blacks may develop multiple sclerosis more often than previously thought. Additionally, the symptoms of ...

Overview  AI now drives personalization, advertising, content, analytics, and customer engagementPredictive intelligence has replaced intuition-led marketi ...

About XTL Biopharmaceuticals Ltd. XTL is an IP Portfolio company that holds 100% of The Social Proxy Ltd. and IP portfolio including hCDR1 for Lupus (SLE) and Sjögren's Syndrome (SS) that the company ...

War drives innovation – and the soon-to-be four year long war in Ukraine has proven that once again. Developments in both tacticts, drone warfare, new weaponry and the likes have helped Ukraine fight ...

Demonstrates how dual-purpose therapeutic targets may address both hepatocellular carcinoma progression and cellular ...